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Abstract Caffeine is a popular work-enhancing supple-
ment that has been actively researched since the 1970s. The
majority of research has examined the effects of moderate
to high caffeine doses (5–13 mg/kg body mass) on exercise
and sport. These caffeine doses have profound effects on
the responses to exercise at the whole-body level and are
associated with variable results and some undesirable side
effects. Low doses of caffeine (\3 mg/kg body
mass, *200 mg) are also ergogenic in some exercise and
sport situations, although this has been less well studied.
Lower caffeine doses (1) do not alter the peripheral whole-
body responses to exercise; (2) improve vigilance, alert-
ness, and mood and cognitive processes during and after
exercise; and (3) are associated with few, if any, side
effects. Therefore, the ergogenic effect of low caffeine
doses appears to result from alterations in the central ner-
vous system. However, several aspects of consuming low
doses of caffeine remain unresolved and suffer from a
paucity of research, including the potential effects on high-
intensity sprint and burst activities. The responses to low
doses of caffeine are also variable and athletes need to
determine whether the ingestion of *200 mg of caffeine
before and/or during training and competitions is ergogenic
on an individual basis.
1 Introduction
The world of sport has always had a high tolerance for the
use of caffeine. For many years, caffeine use in sport was
restricted or controlled, but athletes were still allowed high
urinary caffeine levels (12 lg/mL), before it was consid-
ered illegal. Research in the laboratory had determined that
athletes needed to ingest *10–13 mg caffeine/kg body
mass (bm) in a fairly short period of time to reach this limit
[1, 2]. For a 70 kg person, this amounted to the ingestion of
700–900 mg or the equivalent of *5–7 cups of coffee,
which exceeds typical caffeine use in the general
population.
While studies using these high doses of caffeine repor-
ted ergogenic effects in endurance-type activities, there
were also pronounced effects on the physiological
responses to exercise, including increased heart rates, a
doubling of the catecholamine levels, higher blood lactate
levels, and increased blood free fatty acid (FFA) and
glycerol levels in many subjects [1–4]. The ingestion of
high caffeine doses also produced troubling side effects of
gastrointestinal upset, nervousness, mental confusion,
inability to focus, and disturbed sleeping in some subjects,
especially those who were habitual light caffeine users [2].
When the caffeine dose was reduced to a moderate level
(5–6 mg/kg bm), the ergogenic effects were maintained
and the physiological responses and side effects were also
reduced but were still present [1, 2, 5]. There have also
been many attempts over the years to link these caffeine-
induced peripheral physiological responses to the ergo-
genic benefits of caffeine (see Graham et al. [6] and Spriet
[7, 8] for reviews). However, the administration of a low
caffeine dose (3 mg/kg bm) also produced an ergogenic
effect, with no changes in exercise heart rate and the levels
of catecholamines, lactate, FFA, and glycerol [2]. This
strongly suggested that the ergogenic effect of caffeine was
mediated through the central nervous system (CNS). Pre-
vious work demonstrating caffeine’s antagonistic effect on
adenosine receptors in the body provided the likely
L. L. Spriet (&)
Department of Human Health and Nutritional Sciences,
University of Guelph, Guelph, ON N1G 2W1, Canada
e-mail: lspriet@uoguelph.ca
123
Sports Med (2014) 44 (Suppl 2):S175–S184
DOI 10.1007/s40279-014-0257-8
mechanism of action [9–12]. Work with animal models
also demonstrated a direct effect of caffeine on the CNS
and exercise performance [13].
This paper provides a brief overview of the research that
has examined the administration of low doses of caffeine
on exercise and sport performance. A low dose of caffeine
is defined here as ingesting *3 mg/kg bm or less, which is
*200 mg of caffeine for a 70 kg individual. This is no
more caffeine than may be consumed in 1–2 small cups of
coffee or one large coffee. It is ironic that more research
has examined the efficacy of low caffeine doses for
improving exercise and sport performance in the last
10 years, given that caffeine was removed from the World
Anti-Doping Agency list of restricted or banned substances
in 2004. It may have been expected that the use of higher
caffeine doses would have increased but the majority of
research continues to use moderate (5–6 mg/kg bm) or low
(B3 mg/kg bm) doses.
2 The Changing Landscape of Caffeine Research
Caffeine research in exercise and sport settings has chan-
ged in the past few years. In addition to a greater interest in
examining the potential ergogenic effects of low caffeine
doses in a variety of situations, research has also examined
(1) using time-trial performance tests to simulate real-
world situations versus exercise to exhaustion measures;
(2) administering divided low doses of caffeine before and
during exercise and sport; (3) administering caffeine in
alternate forms such as carbohydrate electrolyte solutions
(CESs), gels, bars, gums and chocolate; (4) caffeine
administration in team-sport settings with sport-specific
simulations of performance; (5) the ergogenic effects of
caffeine in near-elite and elite athlete populations; and (6)
the variable effects of caffeine and the realization that
while some generalizations can be made, attention to
individual responses and trialing with caffeine ingestion is
needed with all athletes.
3 Pharmacological Aspects of Caffeine
Caffeine is rapidly absorbed by the body, when consumed
in coffee and capsules, and appears in the blood within
5–15 min and peaks between 40 and 80 min [2, 14–16].
Plasma caffeine levels rise to *15–20 lmol/L with a low
caffeine dose (3 mg/kg bm), *40 lmol/L with a moderate
dose (6 mg/kg bm), and *60–70 lmol/L with a high dose
of 9 mg/kg bm [2] (Fig. 1). Caffeine also has a long half-
life (*3–5 h), which makes it well suited to interact with
many tissues in the body [16]. However, since caffeine
interacts with many tissues, it is difficult to independently
study its effects on the CNS, the peripheral nervous system,
and the many metabolic tissues in the body (skeletal
muscle, liver, heart, and adipose tissue) at rest and during
exercise. However, it has been shown that the plasma
caffeine levels needed to affect changes in the metabolic
tissues are substantially higher than required to affect the
adenosine receptors in the brain and peripheral nervous
system [9, 11], making it unlikely that there could be major
ergogenic effects with caffeine doses of *3 mg/kg bm or
less where plasma levels are 15–20 lmol/L. The lack of
changes in heart rate and levels of catecholamines, lactate,
FFA and glycerol with this low dose of caffeine supports
this argument.
4 Are Low Doses of Caffeine Ergogenic During
Endurance Exercise?
The interest in caffeine as a potential ergogenic aid during
endurance exercise began in large part due to the research
from David Costill’s laboratory in the late 1970s. Trained
cyclists improved their ride times to exhaustion at *80 %
of maximal oxygen consumption (VO2max), from 75 min in
the placebo condition to 96 min following the ingestion of
330 mg of caffeine in coffee [17]. This caffeine dose was
not low at *5 mg/kg bm, but a second study gave only
250 mg of caffeine at the beginning of exercise and then
another 250 mg in seven doses during exercise and
reported a 20 % increase in the work completed during 2 h
of cycling [18].
Fig. 1 Plasma caffeine concentrations for 1 h at rest and during
exercise to exhaustion at 80–85 % of maximum oxygen uptake in
recreationally active subjects after the consumption of a placebo
(open circles), or 3 (filled squares), 6 (filled triangles) or 9 (filled
circles) mg/kg body mass of caffeine. Data are means ± standard
error (n = 8). exh exhaustion (reproduced from Graham and Spriet
[2], with permission)
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4.1 Laboratory-Based Endurance Cycling Studies
This early work hinted that there may be an ergogenic
effect of low doses of caffeine but it was not until 1995 that
a dose response study examined the effects of 3, 6 and
9 mg/kg bm on the performance of well-trained runners
[2]. Subjects abstained from caffeine use for 48 h, then
consumed a random dose of caffeine or placebo in capsule
form 1 h before running to exhaustion at *85 % VO2max
on a treadmill in ambient laboratory conditions on four
separate occasions. Endurance performance was enhanced
by 22 % over the placebo run of 49.4 ± 4.2 min
(mean ± standard error [SE]) following the ingestion of 3
and 6 mg/kg bm caffeine, but only by 11 % and non-sig-
nificantly following the highest caffeine dose (Fig. 2).
A later study examined the effects of two low caffeine
doses and one moderate caffeine dose given with a CES on
the ability to complete a set amount of work that requir-
ed *1 h [19]. Well-trained cyclists and triathletes ran-
domly received either a placebo or a caffeine dose of 2.1,
3.2 or 4.5 mg/kg bm. The caffeine doses were partitioned
with *60 % of the dose administered *20 min before
exercise, 20 % after 20 min of cycling, and the remaining
20 % at 40 min into the ride. The time-trial performance
was 62.5 ± 1.3 min (mean ± SE) in the placebo trial and
sequentially decreased with increasing caffeine doses to
61.5 ± 1.1, 60.4 ± 1.0 and 58.9 ± 1.2 min. Therefore,
while the low doses of caffeine were performance-
enhancing, this study suggested that the moderate dose
(4.5 mg/kg bm) was the most ergogenic, unlike the results
reported by Graham and Spriet [2] where no differences
were reported between 3 and 6 mg/kg bm.
4.2 Low Caffeine Doses Given Late in Prolonged
Endurance Exercise
An interesting study was published in 2002 suggesting that
well-trained athletes are very sensitive to small doses of
caffeine late in prolonged exercise without taking any
caffeine before exercise [20]. Scientists at the Australian
Institute of Sport were aware that endurance cyclists pre-
ferred to switch from a CES to flat cola in the later stages
of 2- to 6-h road races. They then tested whether this
practice was ergogenic and whether the active ingredi-
ent(s) in the cola was the extra carbohydrate (CHO)
[*11 % CHO vs. *6 % in the CES] or the caffeine. Eight
well-trained cyclists completed four double-blinded and
random trials where they cycled for 102 min at *70 %
VO2max, followed by a time trial where they completed
7 kJ/kg bm as fast as possible (*27 min). The subjects
were mild caffeine users ([150 mg/day) and abstained
from caffeine use for 48 h before every trial. In all trials,
they consumed 5 mL/kg bm of CES at 20, 40 and 60 min.
At 80 and 100 min (and 120 min, if desired) they received
one of four subgroups: CONTROL (decaffeinated cola,
6 % CHO), CAFFEINE (90 mg caffeine ?, 6 % CHO),
Extra CHO (decaffeinated cola, 11 % CHO), and COKE
(90 mg caffeine ?, 11 % cola). Performance times for
CONTROL and CAFFEINE were 27:05 ± 0:42 (min ±
sec; mean ± SE) and 26:36 ± 0:42 min, and for the Extra
CHO and COKE trials were 26:55 ± 0:43 and
26:15 ± 0:43 min. COKE enhanced the time-trial perfor-
mance by 3.3 % relative to CONTROL, with a 2.2 % time-
trial enhancement with CAFFEINE [20]. The authors
concluded that *67 % of the improvement in time-trial
performance was the effect of caffeine, with the remaining
33 % due to the additional CHO. The average total caffeine
intake at 80, 100 (and for some, 120) min of cycling was
only 133 mg or *1.9 mg/kg bm, resulting in plasma levels
of less than 10 lmol/L. These low levels of caffeine intake
and plasma accumulation did not affect any of the physi-
ological responses to exercise, suggesting that the benefi-
cial effects of caffeine were manifested in the CNS late in
exhaustive exercise.
In a similar study, the effects of two low doses of
caffeine on time-trial performance following a prolonged
cycle were examined [21]. Fifteen well-trained cyclists
and triathletes, who were not caffeine users, completed
four trials in a double-blinded and random fashion. They
cycled for 120 min at *60 % VO2max, with five hill
climbs at *85 % VO2max, followed by a time trial where
they completed 6 kJ/kg bm as fast as possible
(*25–30 min). In all trials, subjects consumed 5 mL/kg
bm of CES (6 % CHO, 20 mmol/L sodium) throughout
the 120 min. At 80 min, subjects received one of four
conditions in their CES: placebo (regular CES), CAF100
Fig. 2 Effects of ingesting no caffeine (0) or 3, 6 or 9 mg/kg body
mass of caffeine (dose) on running time to exhaustion at *85 % of
maximum oxygen uptake. Data are means ± standard error (n = 8).
Bars with different letters are significantly different, and bars with the
same letters are not significantly different (reproduced from Graham
and Spriet [2], with permission)
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(100 mg caffeine, *1.5 mg/kg bm), CAF200 (200 mg
caffeine, *3 mg/kg bm), or a random ‘repeat’ of one of
the other three conditions. The ‘repeat’ trial helped com-
plicate the subjects’ perception of what they had received,
and post-trial questionnaires confirmed that the ‘double-
blinding’ was successful. Subjects completed the time trial
in 28:41 ± 0:38 (min ± sec; mean ± SE) in the placebo
condition, were significantly faster in the CAF100
(27:36 ± 0:32 min) trial, and faster again in the CAF200
(26:36 ± 0:22 min) trial. Time-trial performance in the
‘repeat’ trials (five subjects completed two placebo trials,
five completed two CAF100 trials, and five completed two
CAF200 trials) were 27:19 ± 0:30 for the first trial and
27:30 ± 0:35 min for the second trial. Plasma caffeine
levels were not measurable in the placebo condition and
reached 14.9 lmol/L before (120 min) and 13.8 lM after
the time trial in CAF100, and 24.9 and 25.6 lmol/L at the
same time points in CAF200. These results demonstrated
that two low caffeine doses (*1.5 and *3 mg/kg bm)
were ergogenic in well-trained cyclists when ingested late
in an exhaustive ride, during a training-session-ending time
trial [21]. The 200 mg dose was more potent than 100 mg
of caffeine. There were no differences in the physiological
responses during the initial 120 min of submaximal exer-
cise (heart rate, respiratory exchange ratio, and epineph-
rine, glucose, lactate, glycerol, and FFA levels) and prior to
the time trials between the conditions, supporting a CNS
mechanism for the improvement in performance.
4.3 Low Caffeine Doses Ingested Before Endurance
Exercise
In other recent studies that examined the effects of low
doses of caffeine given 1 h before prolonged exercise,
improvements in performance have also been shown, but
not at all doses. Jenkins et al. [22] gave well-trained
cyclists either a placebo or 1, 2 or 3 mg/kg bm caffeine 1 h
before exercise in a randomized design. Subjects cycled for
20 min at 80 % VO2max, completed a 5 min active recov-
ery, and then rode as hard as possible in a 15 min time
period. The work done in 15 min was not improved by
1 mg/kg bm caffeine but increased significantly by 4 %
and 3 % after 2 and 3 mg/kg bm, respectively. The authors
also noted the considerable variability that existed between
subjects [22]. In a similar study, Desbrow et al. [23] gave
well-trained male cyclists either a placebo or 1.5 or 3 mg/
kg bm in a double blind, randomized manner 1 h before
exercise. The subjects cycled for 120 min at *70 %
VO2max, followed by a 7 kJ/kg bm time trial. In this study,
there were no improvements in time-trial time performance
with caffeine [23].
Irwin et al. [24] published an interesting study that was
designed to determine whether a low acute dose of caffeine
(3 g/kg bm) was ergogenic for endurance cycling perfor-
mance following 4 days of caffeine withdrawal or no
withdrawal in habitual caffeine users. Well-trained male
cyclists completed a series of conditions and trials where
they received either a placebo or caffeine 90 min before
exercise, following caffeine withdrawal or no withdrawal.
The exercise was a 1 h cycle time trial at *75 % of
peak sustainable power output. Following a withdrawal
period, performance was improved by 1:49 ± 1:41 min
(mean ± SE) or 3 %, and by 2:07 ± 1:28 min or 3.6 %
following no withdrawal and these results were not sig-
nificantly different. In this study, the habitual caffeine-user
athletes experienced a significant improvement in perfor-
mance from ingesting a low caffeine dose 90 min before
exercise, regardless of whether they withdrew from caf-
feine or not [24]. Finally, in a similar study from the same
laboratory, Desbrow et al. [25] reported that caffeine doses
of 3 and 6 mg/kg bm were ergogenic when well-trained
male subjects completed a 1 h cycle time trial at *75 % of
peak sustainable power output compared with placebo.
Performance improvements were 4.2 and 2.9 % for the two
caffeine doses, prompting the authors to conclude that
doubling the caffeine dose from a low to moderate dose did
not provide additional ergogenic benefits.
5 Are Low Caffeine Doses Ergogenic in Sports?
Much of the experimental work examining the perfor-
mance effects of caffeine in general has occurred in
laboratory settings. While many of these studies have
attempted to mimic field settings (cycling, rowing, run-
ning, etc.), they are removed from the field-based envi-
ronment. An excellent review addressing the need for
more field- and practical-based caffeine studies with
actual sport-specific athletes and performance measures
was published by Burke [26] in 2008. A second review
stressed the importance of using time-trial performance
assessments in laboratory and field studies examining
caffeine and performance [27]. The conclusions of the
meta-analyses of the studies using time trials gave the
same conclusion as earlier studies using time to
exhaustion as the performance measure—caffeine is
ergogenic [27]. However, researchers are well aware of
the difficulty in controlling field studies where environ-
mental and competition characteristics can vary from
test-day to test-day, and that mimicking ‘game perfor-
mance’ can also be difficult either for the single athlete
or when the success of a team is dependent on many
players. Nonetheless, there have been an increasing
number of publications that have assessed the effects of
ingesting caffeine in sport settings. and some of these
studies have used low doses.
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5.1 Running
Wiles et al. [28] published a comprehensive study dem-
onstrating that *150–200 mg of caffeine ingested as cof-
fee 1 h before exercise improved 1,500 m running
performance in well-trained runners. In one experiment,
1,500 m time was improved by 4.2 s with caffeine and, in a
second experiment, where the runners ran the first 1,100 m
at a constant speed and then self-selected their speed over
the final 400 m, running speed was improved over the final
lap by 0.6 km/h, which amounted to 10 m. However, in a
longer road race, 98 runners completed an 18 km run three
times in 8 days in a cool environment and found no effect
of a low dose of caffeine on performance [29]. Subjects
drank 150 mL of either water, a CES, or a CES with
150 mg/L of caffeine, on four occasions during the races—
at the start and after 4.5, 9 and 13.5 km. The total ingested
caffeine was 90 mg or *1.3 mg/kg bm.
More recently, Bridge and Jones [30] reported a 24 s or
1.8 % improvement in 8 km run time on a track with well-
trained male runners when ingesting 3 mg/kg bm of caf-
feine 1 h before racing. Conversely, Schubert et al. [31]
reported no performance-enhancing effects of two ‘energy
drinks’ containing either 80 or 140 mg caffeine versus a
caffeine-free placebo in a 5 km treadmill time trial. How-
ever, this study did not control for the various other
ingredients that were present in the two energy drinks and
therefore was not able to examine the individual effect of
caffeine.
5.2 Stop-and-Go Individual and Team Sports
There have been some studies examining the potential
ergogenic effects of what might be called ‘stop-and-go’
individual and team sports [26], most of which have not
been conducted with low caffeine doses. A study with male
collegiate tennis players demonstrated some improvements
in forehand shot performance when 3 mg/kg bm was
consumed 90 min before a simulated tennis match [32].
Stevenson et al. [33] conducted a comprehensive study of
golf putting performance and alertness when comparing an
energy free, flavoured drink versus a CES with caffeine.
Experienced male golfers drank 5 mL/kg bm of the
selected drink before a round of golf and 2.5 mL/kg bm at
holes 6 and 12. Putting performance (2 and 5 m) was
assessed at each hole and self-rated mood assessments were
done every three holes. Subjects consumed a total of
1.6 mg/kg bm caffeine and 0.64 g/kg bm CHO during the
round. The CES drink with caffeine improved putting
performance and increased feelings of alertness [33]. It
should be pointed out that because both caffeine and CHO
were consumed, the study design did not allow the indi-
vidual effect of caffeine to be determined.
Two recent studies examined the effects of ingesting
3 mg/kg/bm caffeine on volleyball performance in females
and males [34, 35]. In both studies, the caffeine was
administered in an energy drink, with a caffeine-free
energy drink serving as the control. The players completed
a series of volleyball performance tests and played in a
simulated match on both occasions. Ball velocity in a spike
test, several jump tests, the time to complete an agility test,
and the number of successful volleyball actions during the
game all improved in the caffeine trials for both females
and males. The authors stressed that both physical perfor-
mance and the accuracy of the volleyball skills were
improved with caffeine ingestion in a commercially
available energy drink [34, 35].
Two team-sport studies also suggested that low doses of
caffeine may improve aspects of soccer and rugby playing,
although the studies gave 3.7 and 4.0 mg/kg bm caffeine,
respectively. In the soccer study, players completed two
90 min intermittent shuttle running trials, consuming a
CES on one occasion and the same CES with caffeine on
the other [36]. The solutions were ingested before the trial
and every 15 min throughout. Adding caffeine to the CES
improved sprint performance, counter-movement jumping,
and offset the fatigue-induced decline in the self-selected
components of performance [36], In the rugby study, the
players again were given either a placebo, CES, or a CES
with caffeine before and during a rugby-union-specific
shuttle running protocol [37]. In the CES with caffeine
trial, the likelihood of a 2 % improvement was 98 % over
placebo and 48 % over CES alone. Motor skills were also
performed faster in the CES plus caffeine trial versus the
other two trials, and 15 m sprints were faster than placebo.
The authors concluded that the co-ingestion of CHO and
caffeine was likely to benefit rugby union performance
[37]. It would be interesting to repeat aspects of these
studies with slightly lower caffeine doses.
6 Low Caffeine Doses and High-Intensity Exercise that
Relies on Anaerobic Energy Production
Many forms of exercise and sports are reliant on bursts of
activities or sprints, where the dominant portion of the
energy production must be provided by non-oxidative or
‘anaerobic’ energy sources [38, 39]. Phosphocreatine (PCr)
and adenosine triphosphate (ATP) production in the gly-
colytic pathway are the two main pathways for the pro-
duction of anaerobic energy. While the PCr store can be
consumed in a few seconds and the heavy use of the gly-
colytic pathway can lead to acidosis in muscle cells, these
pathways are able to provide energy very quickly and in
large quantities for short periods of time to allow athletes to
complete very powerful movements [38, 39]. In many
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sports, the ability to repeatedly burst or sprint is essential to
success. In stop-and-go and power-based sports, these
bursts often occur on the back of already high energy
production from the aerobic system. The question for this
paper is whether this type of activity is improved by caf-
feine ingestion and specifically low doses of caffeine.
Early reviews generally concluded that there was no
benefit of caffeine for burst activities [8, 9] as the majority
of studies reported no effects. However, as the number of
studies examining this type of work increased, more recent
reviews suggested that there were benefits in about 50 % of
the published studies in power-based sports, resistance
training paradigms, repeated high-intensity intermittent
exercise, and isometric and isokinetic muscle force pro-
duction and endurance [40, 41]. For example, indices of
strength in highly resistance-trained males were improved
with caffeine ingestion of 7 mg/kg bm [42], and more
weight was lifted and a greater peak power was attained in
a Wingate test in competitively trained males following the
ingestion of 5 mg/kg bm caffeine [43]. Short-term high-
intensity cycling lasting about 1 min was also improved by
the ingestion of 5 mg/kg bm caffeine in two studies [44,
45]. However, these studies did not measure lower doses of
caffeine.
Almost no work exists in this area with low caffeine doses.
However, a research group in France reported ergogenic
effects of a 250 mg dose of caffeine on work maximum in a
test of maximal anaerobic power [46] and in repeated 100 m
sprints in trained swimmers [47]. More recently, Astorino
et al. [48] examined the effects of ingesting either 2 or 5 mg/kg
bm caffeine on isokinetic knee flexion performance and
reported no effect of the low caffeine dose on peak torque or
knee extension/flexion total work or power. Therefore, the
conclusion here must be that very little ‘low-dose’ caffeine
research has been done in this area, although it may be argued
that this stems from the somewhat equivocal results that have
been reported with moderate and high doses of caffeine on
burst and sprint activities.
7 Low Caffeine Doses and Vigilance, Alertness, Mood
and Cognitive Function
There is a large literature that has examined the use of
caffeine for maintaining vigilance, alertness, mood, exec-
utive control, and related parameters. This research often
investigates situations where maintaining vigilance and
performance is critical, as in the military and other pro-
fessions where people are awake for long periods of time.
Lieberman and colleagues have worked in this area for
many years and published many papers on the potential
usefulness of caffeine. For example, they gave 20 subjects
four random doses of caffeine (32, 64, 128 and 256 mg)
and assessed auditory vigilance and reaction time and
mood in healthy volunteers [49]. All four caffeine doses
improved the performance of these tests. More recent work
indicated that the optimal dose of caffeine is *200 mg
when vigilance, mood, alerting, orienting, and executive
control were assessed against other caffeine doses or no
caffeine [50, 51]. The plateauing of beneficial effects
at *200 mg of caffeine is believed to match the adeno-
sine-mediated effects on dopamine-rich areas in the human
brain and their involvement in the executive control of
visual attention and alerting [49]. Hogervorst et al. [52, 53]
published two studies suggesting that low doses of caffeine
improve cognitive performance during and after strenuous
exercise. The first study had trained cyclists/triathletes
complete an all-out 1 h cycling time trial on five occasions.
They randomly received a water placebo, a CES placebo,
or one of three CESs with either, 150, 225 or 320 mg of
caffeine before and during the cycle [52]. Cognitive tests,
including memory, psychomotor and attention tasks, were
carried out before and immediately after the time trial. The
two low doses of caffeine improved all cognitive functions
following exercise and the higher dose provided no further
improvement. These results clearly demonstrated that the
ability to concentrate and make decisions was improved by
caffeine immediately after exhausting exercise, leading to
the suggestion that this effect would also be present in the
later stages of exercise [52]. A second study directly
measured the effects of ingesting 100 mg of caffeine in an
energy bar (with 45 g CHO) before exercise and again at
45 and 115 min of a 3 h cycle at 60 % VO2max, followed by
a time-to-exhaustion trial at 75 % VO2max on cognitive
function measures [53]. A second trial gave the energy bar
only, and a third was a placebo trial with an energy- and
caffeine-free beverage. Cognitive function tests (Stroop
test and rapid visual information processing tests) were
administered before exercise and after 70 and 140 min of
the trial and 5 min after the trial. Performance was best
following caffeine ingestion (total of 300 mg before and
during exercise) on the complex information processing
tests, especially after 140 min of cycling. Cycle-ride time
to exhaustion was also the longest in the caffeine trial.
These results suggest that low-dose caffeine ingestion
during prolonged exercise helps with decision making and
could be useful for all sports where critical decision mak-
ing is important for success late in an event or game [53].
8 Low Caffeine Doses and Related Issues
8.1 Pain
There is a large body of literature reporting that the per-
ception of pain during moderate and intense exercise is
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reduced following the ingestion of 5–10 mg/kg bm caf-
feine in men and women [54–56]. However, not all studies
have reported an attenuation of pain during strenuous or
high-intensity exercise. Astorino et al. [57] reported no
effect of 2 or 5 mg/kg bm caffeine on pain perception
during repeated bouts of high-intensity exercise. A second
study reported that a 3 mg/kg bm caffeine dose 1 h before
exercise and another 3 mg/kg bm dose 45 min into a 2 h
submaximal ride, followed by a 15 min performance trial,
reduced leg pain by 27 % in a trial in the heat (33 C) but
had no effect in a cool environment (12 C) [58]. It should
be noted that pain perception was 74 % higher in the hot
versus cool trial and caffeine was able to partially attenuate
this.
8.2 Exercise in the Heat
Exercising in a hot environment is less well tolerated than
exercise in a cool environment and several studies have
examined whether caffeine may counteract the fatigue of
exercise in the heat. The literature is mixed, with some
studies reporting that 5, 6 or 9 mg/kg bm caffeine did not
improve endurance performance in the heat [59, 60], with
others suggesting that 6 mg/kg bm is ergogenic [58, 61].
However, the author is not aware of any studies that have
examined the effects of low doses of caffeine in the heat,
especially late in exhaustive exercise.
8.3 Gastrointestinal Function
One study examined the effects of low doses of caffeine
(95 mg) in a CES on gastrointestinal function given before
exercise and at 20 and 40 min into 90 min of cycling
at *70 % VO2max [62]. Caffeine (285 mg in total) had no
effect on gastric emptying, gastric pH, orocecal transit
time, and intestinal permeability. Interestingly, glucose
absorption was increased in the caffeine trial. A subsequent
study examining the effects of caffeine on glucose
absorption also reported an increase but with a high caf-
feine dose of 10 mg/kg bm during cycling [63], while two
other studies reported no effect with 1.5, 3 and 5.3 mg/kg
bm [23, 64]. So on balance, it seems unlikely that low
doses of caffeine would affect glucose absorption on a
consistent basis.
8.4 Immune System
Natural killer (NK) cells comprise about 5–20 % of all
lymphocytes in the blood, and represent the first line of
defence against infectious agents as they do not need prior
sensitization or require specific antigen recognition to
attack target cells [65]. They also play an important role in
defence against viral infection and tumor immune
surveillance [65]. The functional abilities of NK cells
decreases after intense exercise, and this decrease may
explain why there is a high incidence of viral respiratory
infection in elite athletes [66]. The NK cells have A1 and
A2 adenosine receptors, and the exercise-induced decreases
in activation may be due to increased adenosine and epi-
nephrine concentrations. With this in mind, and the fact
that caffeine is an adenosine receptor antagonist, Fletcher
and Bishop [67] examined the effect of moderate (6 mg/kg
bm) and low (2 mg/kg bm) doses of caffeine on NK cell
function. Endurance-trained males cycled for 90 min at
70 % VO2max on three occasions after ingesting no caf-
feine, the low caffeine dose, or the high dose. Both doses of
caffeine increased both the unstimulated, or natural state of
NK cell activation, and the antigen-stimulated NK cell
activation 1 h after exercise; this response was not dose-
dependent. The authors hypothesized that caffeine may
have antagonized the adenosine receptors on the NK cells,
leading to the increased state of activation following
exercise [67].
9 Delivery of Low Caffeine Doses in Alternative Forms
Caffeine administration in most research settings is deliv-
ered in coffee or in tablets/capsules along with water,
where there is a known amount of caffeine ingested. Caf-
feine is also available in gels and bars and in some sports
drinks for use by athletes before and during athletic events.
It might be assumed that the appearance of caffeine in the
blood would be slightly delayed with gels and bars com-
pared with ingestion in coffee or tablets/capsules ingested
with water but this does not appear to have been studied.
The study discussed in Sect. 7 in which the caffeine was
given in a bar, produced an ergogenic effect, therefore any
absorption effects may be small [53].
Another form of delivery that has received some interest
is chewing gum. Kamimori et al. [16] compared the rate of
absorption of 50, 100 and 200 mg caffeine in chewing gum
versus the same doses in capsules in healthy volunteers. All
subjects had abstained from caffeine for 20 h and there
were 12 subjects in each treatment group. Eight blood
samples were taken from 5 to 90 min after caffeine
ingestion, and eight more were taken from 2 to 29 h post-
administration. The rate of caffeine absorption was sig-
nificantly faster from the gum versus the capsules, sug-
gesting that absorption from the buccal mucosa in the
mouth was a contributing factor when chewing gum was
administered [14, 16]. However, over time, the gum and
capsule formulations provided essentially the same
amounts of caffeine for the 100 and 200 mg doses. If rapid
caffeine absorption is required in a sport situation, chewing
gum may be the desired form of delivery. A second study
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demonstrated that plasma caffeine levels can be maintained
at desired concentrations with repeated doses (2 h apart) of
caffeine delivered in gum [68].
A few studies have examined the potential ergogenic
effect of caffeine administration in gum. Ryan et al. [69]
administered two pieces of caffeinated chewing gum
(200 mg total) at one of three time points, either 35 or
5 min before exercise or 15 min into cycling at 85 %
VO2max to exhaustion lasting *30–35 min. A placebo was
given at the other two time points and all three points
during the control trial. The subjects were college-age,
physically active male volunteers. The caffeine in the gum
did not improve endurance performance at any of the
administration times [69]. In a follow-up study, Ryan et al.
[70] gave 300 mg of caffeine in gum either at 120 min,
60 min or 5 min before exercise. In the placebo trial,
subjects received no caffeine. The subjects in this study
were well-trained cyclists, and the performance task was
cycling at 75 % VO2max for 15 min, followed by a time
trial where 7 kJ/kg bm of work was completed as fast as
possible. Caffeine improved cycling performance only in
the trial where the caffeine was administered 5 min before
exercise compared with the placebo trial [70].
One report examined the effects of caffeine given as
chewing gum on repeated cycle sprint ability [71]. Com-
petitive cyclists completed four sets of 30 s maximal
sprints, with five sprints/set and each sprint was separated
by 30 s of active recovery. Caffeine (240 mg or *3 mg/kg
bm) was administered following the second set and the rate
of power output decline in the final two sets (10 sprints)
was significantly reduced by the caffeinated gum compared
with the placebo group. A second study reported that
standing shot-put performance was improved following the
administration of 100 mg caffeine in gum [72].
Another emerging area for exposing the body to caffeine
is mouth rinsing. The premise is that small volumes of fluid
containing high concentrations of caffeine could be mouth-
rinsed for 5–10 s periods. While this is unlikely to result in
significant caffeine absorption, it would test the possibility
that caffeine is sensed in the mouth with signals sent to the
CNS. Doering et al. [73] had subjects complete a 1 h
cycling time trial on two occasions. They mouth-rinsed for
10 s with 25 mL volumes containing either 35 mg caffeine
or no caffeine on eight occasions during the time trials.
Time-trial performance was unaffected by the caffeine
mouth-rinses and no increase in plasma caffeine was
detected. However, an earlier report by Beaven et al. [74]
had subjects complete 5 9 6 s sprints with 24 s of active
recovery between sprints. Subjects mouth-rinsed with
25 mL volumes containing either a CHO solution, a 1.2 %
caffeine solution (*300 mg caffeine) or a non-caloric
solution for 5 s just prior to each sprint. The caffeine
mouth-rinse improved peak power in the first sprint only.
When caffeine and CHO were combined in a second study
and compared with CHO only, the caffeinated mouth-rinse
condition again improved peak power in the first sprint
[74]. The authors did not measure plasma caffeine to see if
mouth rinsing with a high caffeine-containing solution
resulted in significant absorption of caffeine, and it is not
clear why the caffeine effect was only present in the first of
five sprints. Further work will be needed to determine
whether mouth rinsing with caffeine is ergogenic in the
absence of absorption into the blood.
Lastly, there are commercially available products where
caffeine can be delivered in aerosol form, with some pro-
ducts claiming to deliver 100 mg of caffeine per spray or
squirt of aerosol. There are no published reports measuring
the time of caffeine absorption into the blood using these
products, and it seems unlikely that these claims are true.
However, delivering caffeine in a gas form into the lungs
sets up the possibility that rapid absorption could occur. In
this case the absorbed caffeine would be delivered straight
from the lungs to the heart and this would not be desirable
in some cases. An absorption study measuring the effec-
tiveness of these products is needed.
10 Conclusions
It has long been known that moderate to high caffeine
doses (5–13 mg/kg bm) ingested *1 h before and during
exercise increase endurance exercise performance in lab-
oratory and sport field settings. Recent work also suggests
that caffeine is ergogenic in some short-term high-intensity
exercise and sport situations and also in team-sport simu-
lations. Lower caffeine doses (B3 mg/kg bm, *200 mg)
taken before exercise also increase athletic performance,
and recent evidence has demonstrated an ergogenic effect
of low and very low doses of caffeine taken late in pro-
longed exercise. Low caffeine doses do not alter exercise-
induced changes in peripheral whole-body responses to
exercise and are associated with few, if any, side effects.
Low doses of caffeine (*200 mg) have also been shown to
improve vigilance, alertness and mood, and improve cog-
nitive processes during and following strenuous exercise.
Therefore, the ergogenic effect of low caffeine doses
appears to result from alterations in the CNS. However,
many aspects of consuming low doses of caffeine remain
unresolved and suffer from a lack of research. As the
response to caffeine consumption is variable, athletes need
to determine whether the ingestion of *200 mg of caffeine
before and/or during training and competitions is ergogenic
on an individual basis.
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